Skip to main content
logo
Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
145.50
+6.50 (4.68%)
At close: Sep 7, 2026

TPEX:7871 Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-155.83-1,107-440.32268.21
Depreciation & Amortization
9.189.187.353.76
Loss (Gain) From Sale of Assets
---0.02-
Loss (Gain) From Sale of Investments
-43.48-9.67--
Loss (Gain) on Equity Investments
--0.31-
Stock-Based Compensation
-2.54.021.71
Other Operating Activities
14.48942.49226.55-372.17
Change in Accounts Receivable
9.447.17-3.29-1.68
Change in Accounts Payable
16.4326.67-33.664.98
Change in Unearned Revenue
----9.83
Change in Other Net Operating Assets
-5.24-3.81-0.65-0.32
Operating Cash Flow
-155.03-131.97-239.7-105.33
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.5-0.5-9.97-0.22
Sale of Property, Plant & Equipment
--0.02-
Sale (Purchase) of Intangibles
--5--
Investment in Securities
43.55---0.29
Other Investing Activities
-0.10.060.610.02
Investing Cash Flow
42.95-5.44-9.34-0.49

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Short-Term Debt Issued
-634.6309.461.01
Total Debt Issued
-634.6309.461.01
Long-Term Debt Repaid
--10.66-11-1.08
Lease Payments
-4.22-4.16-4.5-
Net Debt Issued (Repaid)
-10.72623.95298.459.93
Issuance of Common Stock
201.43247.161.651.91
Financing Cash Flow
190.71871.1300.0561.83

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Foreign Exchange Rate Adjustments
47.5541.556.570.97
Net Cash Flow
126.18775.2457.59-43.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-155.53-132.48-249.67-105.55
Free Cash Flow Growth
----
Free Cash Flow Margin
-137.23%-263.44%-31091.78%-410.76%
Free Cash Flow Per Share
-1.17-1.68-11.28-1.32
Levered Free Cash Flow
-75.83-84.8-176.75-
Unlevered Free Cash Flow
-75.33-84.2-175.93-
Free Cash Flow After Leases
-159.75-136.63-254.16-105.55

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
0.80.971.310.5
Change in Working Capital
20.6230.03-37.59-6.85